Significance of diagnostic transcranial magnetic stimulation during radiotherapy

Artem V. Kartashev , Vladislav Yu Chirkin , Nikolaj V. Il’in , Vladislav B. Voitenkov , Yulia N. Vinogradova

Kazan medical journal ›› 2022, Vol. 103 ›› Issue (2) : 202 -210.

PDF (339KB)
Kazan medical journal ›› 2022, Vol. 103 ›› Issue (2) : 202 -210. DOI: 10.17816/KMJ2022-202
Theoretical and clinical medicine
research-article

Significance of diagnostic transcranial magnetic stimulation during radiotherapy

Author information +
History +
PDF (339KB)

Abstract

Background. Transcranial magnetic stimulation is a non-invasive, painless method that stimulates the cerebral cortex using short magnetic pulses. The information obtained as a result of the research can be further used for an objective assessment of the therapy.

Aim. Evaluation the reliability of transcranial magnetic stimulation technique as a neurophysiological monitoring tool in patients with malignant brain tumors.

Material and methods. There were two groups as a study objects: patients with large-focal solitary lesions of the central nervous system (glioma) who underwent radiotherapy (n=20), median age 49.5±5.3 (39; 60) years, and a comparison group of neurologically healthy individuals (n=16), median age 48.5±6.3 (43.0; 58.8) years. There were no statistically significant age differences between the studied groups. All patients underwent diagnostic transcranial magnetic stimulation before and after therapy. The Mann–Whitney test was used to make comparisons between the two groups. A p value <0.05 was considered statistically significant.

Results. During transcranial magnetic stimulation in patients with malignant brain neoplasms, signs of impaired conduction along the central motor pathways were recorded in 50% of cases, and in total, signs of impaired conduction of all degrees of severity along the central motor pathway were detected in 90% of cases. Carrying out diagnostic transcranial magnetic stimulation according to a single-pulse protocol makes it possible to predict the further course of the recovery period. The use of transcranial magnetic stimulation in dynamics revealed an improvement in conduction along the central motor pathways in patients with malignant brain neoplasms. The obtained statistically significant differences allow us to conclude that transcranial magnetic stimulation can be used for an objective assessment of the state of the motor pathways in patients with neurooncological diseases.

Conclusion. Diagnostic transcranial magnetic stimulation is applicable in large-focal solitary lesions of the central nervous system, since it allows assessing the state of the motor pathways and the functional activity of the brain at different stages of this condition.

Keywords

radiotherapy / transcranial magnetic stimulation / brain tumors / magnetic coil / neurodegenerative diseases / glioma / evoked motor responses

Cite this article

Download citation ▾
Artem V. Kartashev, Vladislav Yu Chirkin, Nikolaj V. Il’in, Vladislav B. Voitenkov, Yulia N. Vinogradova. Significance of diagnostic transcranial magnetic stimulation during radiotherapy. Kazan medical journal, 2022, 103(2): 202-210 DOI:10.17816/KMJ2022-202

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, Di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, Hallett M, Lefaucheur JP, Langguth B, Matsumoto H, Miniussi C, Nitsche MA, Pascual-Leone A, Paulus W, Rossi S, Rothwell JC, Siebner HR, Ugawa Y, Walsh V, Ziemann U. Non-invasive electrical and magne­tic stimulation of the brain, spinal cord, roots and peri­pheral nerves: Basic principles and procedures for routine cli­nical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126(6):1071–1107. DOI: 10.1016/j.clinph.2015.02.001.

[2]

Dobek CE. Music modulation of pain perception and pain-related activity in the brain, brain stem, and spinal cord: A functional magnetic resonance ima­ging study. J Pain. 2010;15(10):1057–1062. DOI: 10.1016/j.jpain.2014.07.006.

[3]

Nikitin SS, Kurenkov AL. Magnitnaya stimulya­tsiya v dia­gnostike i lechenii bolezney nervnoy sistemy. Rukovodstvo dlya vrachey. (Magnetic stimulation in the dia­gnosis and treatment of diseases of the nervous system. A guide for doctors.) Moscow: SASHKO; 2003. 378 p. (In Russ.) DOI: 10.17816/PTORS4433-40.

[4]

Никитин С.С., Куренков А.Л. Магнитная стимуляция в диагностике и лечении болезней нервной системы. Руководство для врачей. М: САШКО; 2003. 378 с. DOI: 10.17816/PTORS4433-40.

[5]

Voytenkov VB, Skripchenko NV, Klimkin AV, Mally Ju. Transcranial magnetic stimulation as a diagnostic and therapeutic tool. Neurological journal. 2015;20(5):4–13. (In Russ.)

[6]

Войтенков В.Б., Скрипченко Н.В., Климкин А.В., Mally Ju. Транскраниальная магнитная стимуляция как диагностическая и терапевтическая методика. Неврологический журнал. 2015;20(5):4–13.

[7]

Najib U, Horvath JC. Transcranial magnetic stimulation (TMS) safety considerations and recommendations. New York: Humana Press; 2014. 156 p. DOI: 10.1007/978-1-4939-0879-02.

[8]

Rossi S, Hallett M, Rossini PM, Pascual-Leone A. The safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of trans­cranial magnetic stimulation in clinical practice and ­research. Clin Neurophysiol. 2009;120(12):2008–2039. DOI: 10.1007/978-3-319-54918-74.

[9]

Eryılmaz G, Sayar GH, Özten E, Gül IG, Yorbik Ö, Işiten N, Bağcı E. Follow-up study of children whose mo­thers were treated with transcranial magnetic stimulation during pregnancy: Preliminary results. Neuromodulation. 2015;18(4):255–260. DOI: 10.1111/ner.12231.

[10]

Pridmore S, Turnier-Shea Y, Rybak M, Pridmore W. Transcranial Magnetic Stimulation (TMS) during pregnancy: a fetal risk factor. Australas Psychiatry. 2021;29(2):226–229. DOI: 10.1177/1039856221992636.

[11]

Dzierma Y, Schuermann M, Melchior P, Nuesken F, Oertel J, Rübe C, Hendrix P. Optimizing adjuvant stereotactic radiotherapy of motor-eloquent brain metastases: Sparing the nTMS-defined motor cortex and the hippocampus. Front Oncol. 2021;11:628007. DOI: 10.3389/fonc.2021.628007.

[12]

Schwendner MJ, Sollmann N, Diehl CD, Oechsner M, Meyer B, Krieg SM, Combs SE. The role of naviga­ted transcranial magnetic stimulation motor mapping in adjuvant radiotherapy planning in patients with supratentorial brain metastases. Front Oncol. 2018;8:424. DOI: 10.3389/fonc.2018.00424.

[13]

Diehl CD, Schwendner MJ, Sollmann N, Oechsner M, Meyer B, Combs SE, Krieg SM. Application of presurgical navigated transcranial magnetic stimulation ­motor mapping for adjuvant radiotherapy planning in patients with high-grade gliomas. Radiother Oncol. 2019;138:30–37. DOI: 10.1016/j.radonc.2019.04.029.

[14]

Islam M, Cooray G, Benmakhlouf H, Hatiboglu M, Sinclair G. Integrating navigated transcranial magne­tic stimulation motor mapping in hypofractiona­ted and single-dose gamma knife radiosurgery: A two-patient case series and a review of literature. Surg Neurol Int. 2020;11:29. DOI: 10.25259/SNI_406_2019.

[15]

Tokarev AS, Rak VA, Sinkin MV, Evdokimova OL, Stepanov VN, Koynash GV, Krieg SM, Krylov VV. Appliance of navigated transcranial magnetic stimulation in radiosurgery for brain metastases. J Clin Neurophysiol. 2020;37(1):50–55. DOI: 10.1097/WNP.0000000000000621.

[16]

Kartashev AV, Voitenkov VB, Kiseleva LN. Transcranial magnetic stimulation in the diagnosis of cerebral gliomas. Voprosy onkologii. 2013;59(2):22–26. (In Russ.)

[17]

Карташев А.В., Войтенков В.Б., Киселёва Л.Н. Транскраниальная магнитная стимуляция в диагностике глиом головного мозга. Вопросы онкологии. 2013;59(2):­22–26.

[18]

Ekusheva EV, Vendrova MI, Danilov AB, Vein AM. The contributions of the right and left hemispheres of the brain to the polymorphism and heterogeneity of pyramidal syndrome. Neurosci Behav Physiol. 2005;35(3):229–234. DOI: 10.1007/s11055-005-0047-8.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF (339KB)

109

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/